-
What’s Hot: Enduro Royalty Trust (NYSE:NDRO), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Diageo plc (NYSE:DEO), Territorial Bancorp Inc. (NASDAQ:TBNK), CAMAC Energy (NYSEMKT:CAK)
RBC Capital lowered shares of Enduro Royalty Trust (NYSE:NDRO) from an outperform rating to a sector perform rating in a research report released on Wednesday morning, TheFlyOnTheWall.com reports. Enduro Royalty Trust (NYSE:NDRO) in last trading activity advanced 20.66% to close at $6.19. Company weekly performance is 11.93% while its quarterly performance stands at -48.37%. Enduro…
-
Investors Alert: Concur Technologies (NASDAQ:CNQR), Infinity Pharmaceuticals (NASDAQ:INFI), Macy’s (NYSE:M), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Camtek (NASDAQ:CAMT)
Concur Technologies, Inc. (NASDAQ:CNQR) has earned a consensus rating of “Hold” from the twenty analysts that are covering the company. One analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have…
-
Eye Catching Stocks: Amkor Technology (NASDAQ:AMKR), Companhia Energetica Minas Gerais (ADR) (NYSE:CIG), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Deere & Company (NYSE:DE), FRP
Amkor Technology, Inc. (NASDAQ:AMKR) was upgraded by equities research analysts at Sidoti from a “neutral” rating to a “buy” rating in a research note issued to investors on Monday. Amkor Technology, Inc. (NASDAQ:AMKR) in last trading activity increased 0.59% to close at $6.81. Company weekly performance is 6.57% while its quarterly performance stands at -32.84%.…
-
Investors Are Watching: Newmont Mining Corporation (NYSE:NEM), Maxim Integrated Products (NASDAQ:MXIM), Laredo Petroleum (NYSE:LPI), Invacare (NYSE:IVC), Ultragenyx Pharmaceutical (NASDAQ:RARE)
Newmont Mining Corporation (NYSE:NEM) ‘s stock had its “neutral” rating restated by Zacks in a report released on Wednesday. They currently have a $21.00 price target on the stock. Zacks‘s target price suggests a potential upside of 9.89% from the company’s current price. Newmont Mining Corporation (NYSE:NEM) in last trading activity advanced 2.46% to close…
-
Big Movers: SunPower Corporation (NASDAQ:SPWR), Applied Materials (NASDAQ:AMAT), LSI Industries Inc. (NASDAQ:LYTS), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), LaSalle Hotel Properties (NYSE:LHO)
SunPower (NASDAQ:SPWR) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $0.30 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.24 by $0.06. The company had revenue of $662.70 million for the quarter, compared to the consensus estimate of $628.70 million. During the same quarter in the prior…
-
Trending Tickers: BioCryst Pharmaceuticals (NASDAQ:BCRX), Boston Scientific Corporation (NYSE:BSX), Polypore International Inc. (NYSE:PPO), Affiliated Managers Group Inc. (NYSE:AMG), Ultragenyx Pharmaceutical (NASDAQ:RARE)
Shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) have earned a consensus recommendation of “Buy” from the thirteen brokerages that are covering the stock, AnalystRatingsNetwork.com reports. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) in last trading activity decreased -3.03% to…
-
Hot Alert: Silver Wheaton Corp. (NYSE:SLW), Goldcorp Inc. (NYSE:GG), China Life Insurance Co. (NYSE:LFC), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Modine Manufacturing (NYSE:MOD)
Equities research analysts at Canaccord Genuity cut their price target on shares of . Silver Wheaton Corp. (NYSE:SLW) from C$30.00 to C$29.00 in a research note issued to investors on Thursday. The firm currently has a “buy” rating on the stock. Canaccord Genuity’s price target indicates a potential upside of 33.64% from the company’s current…
-
Trending Stocks: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Transocean (NYSE:RIG), Access Midstream Partners, L.P. (NYSE:ACMP), MAM Software Group (NASDAQ:MAMS), CenterPoint Energy (NYSE:CNP)
On October 30, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced that the European Commission has granted orphan medicinal product designation for recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23 or KRN23 or UX023 for the treatment of X-linked hypophosphatemia or XLH. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) in last trading activity increased 0.02% to close at $44.59.…
-
Why Making Dramatic Moves: Skyworks Solutions Inc. (NASDAQ:SWKS), NanoString Technologies (NASDAQ:NSTG), Symmetry Medical (NYSE:SMA), Acme United (NYSEMKT:ACU), Ultragenyx Pharmaceutical (NASDAQ:RARE)
On 29 October Skyworks Solutions Inc. (NASDAQ:SWKS) announced it is enabling a variety of wireless solutions for high fidelity streaming music platforms. Skyworks has captured design wins with virtually every tier-one original equipment manufacturer (OEM) in this fast growing market segment. Skyworks’ front-end devices integrate power amplifiers, low noise amplifiers, switches, filters and power detectors.…
-
Investors Watch List : ARM Holdings plc (NASDAQ:ARMH), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Meredith Corporation (NYSE:MDP), RadNet, Inc. (NASDAQ:RDNT), Banco de Chile (NYSE:BCH)
ARM Holdings plc (NASDAQ:ARMH) recently announced a dividend, which is scheduled for Friday, October 3rd. Investors of record on Wednesday, September 3rd will be paid a dividend of GBX 2.52 ($0.04) per share. This represents a dividend yield of 0.29%. The ex-dividend date of this dividend is Wednesday, September 3rd. ARM Holdings plc (NASDAQ:ARMH) in…